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Abstract: When conducting a paired 2 × 2 crossover design, each subject
is paired with another subject with similar characteristics. The pair is then
randomized to the same sequence of two treatments. That is, the two sub-
jects receive the first experimental treatment, and then they cross over and
receive the other experimental treatment(s). The paired 2× 2 crossover design
that was used in the Beta Adrenergic Response by GEnotype (BARGE) Study
conducted by the National Heart, Lung and Blood Institute’s Asthma Clini-
cal Research Network (ACRN) has been described elsewhere. When the data
arising from such a design are balanced and complete – or if at least any miss-
ingness that occurs is at random – general linear mixed-effects model methods
can be used to analyze the data. In this paper, we present a method based
on a pattern-mixture model for analyzing the data arising from a paired 2× 2
crossover design when some of the data are missing in a non-ignorable fashion.
Because of its inherent scientific interest, we focus our particular attention on
the estimation of the treatment-by-type of subject interaction term. Finally,
we illustrate the pattern-mixture model methods described in this paper on
the data arising from the BARGE study.
1. Introduction
Two important design principles are occasionally used in clinical trials: 1) A subject
is “matched” or “paired” with another subject with similar characteristics to reduce
the chance that other variables obscure the primary comparison of interest. 2) A
subject serves as his or her own control by “crossing over” from one treatment to
another during the course of an experiment. Experiments employing the first design
principle are called matched pair designs (Cochran [1]), while those employing the
second are called crossover designs (Jones and Kenward [2], Ratkowsky et al. [3]
and Senn [4]).
There are situations in which it may be beneficial to use the two design princi-
ples simultaneously. That is, it may be advantageous to conduct a “paired crossover
design.” For such a design, each subject and his/her paired counterpart are ran-
domized to the same treatment sequence. That is, they receive one experimental
treatment, and then cross over and receive the other experimental treatment(s) at
the same time. A paired crossover design was recently used in three clinical tri-
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als conducted by the National Heart, Lung and Blood Institute’s Asthma Clinical
Research Network (ACRN) (Kephart [5]; www.acrn.org).
In particular, the Beta Adrenergic Response by GEnotype (BARGE) Study (Is-
rael et al. [6]) used a paired 2 × 2 crossover design to compare the regular use of
inhaled albuterol (A) to placebo (P) in patients with the Arg/Arg genotype and
the Gly/Gly genotype at the 16th position of the beta-agonist receptor gene. It was
hypothesized that the scheduled daily use of inhaled albuterol, the most common
treatment for patients with mild to moderate asthma, actually had a detrimental
effect on the lung function of patients with the Arg/Arg genotype (R) but not
patients with the Gly/Gly genotype (G). The primary research question therefore
concerned whether or not the treatment effects differed for the two genotypes. That
is, the primary hypothesis concerned inference about whether the interaction pa-
rameter:
γ = (µRA − µRP )− (µGA − µGP )
is 0, where µkl is the population mean lung function of genotype k patients on
treatment l.
To achieve an efficient comparison of the treatments within each genotype, a 2×2
crossover design was used within each genotype k. Because a subject’s genotype
is a pre-determined characteristic, subjects could not be randomly allocated to
genotypic group. Therefore, to minimize confounding caused by potential differences
in the baseline lung function of the two genotypic groups, each subject of genotype
R was matched to a subject of genotype G with similar baseline lung function. The
matched subjects were randomly assigned to the same sequence of the crossover
design, and an eight-week washout period was placed between the two treatment
periods (Table 1).
At the conclusion of the BARGE Study, each pair of subjects j of sequence s
ideally yielded the quadrivariate response Ysj = (YsjRA , YsjRP , YsjGA, YsjGP ), a
vector containing the subjects’ changes in lung function. Unfortunately, as should
be expected when conducting any clinical trial, measurements in the BARGE Study
were not always collected as planned. That is, some subjects missed one or more
planned visits or completely dropped out of the study. In this paper, we present
a method based on a pattern-mixture model for analyzing the data arising from a
paired 2× 2 crossover design when some of the data are missing.
In general, if yi = (yi1, . . . , yip)
′ denotes the p × 1 vector of intended repeated
measurements on subject i and mi = (mi1, . . . ,mip)
′ represents a p × 1 vector of
random indicator variables denoting whether or not response yij is observed, then
pattern-mixture models factor the joint distribution of yi and mi as:
pi [yi,mi|Xi] = pi [yi|Xi,mi]× pi [mi|Xi] ,
where Xi denotes fixed covariates or design matrices. That is, in short, the data are
stratified by their patterns of missingness, and then a separate model is specified
Table 1
Paired crossover design for the BARGE Study. Pairs of subjects were randomized
to either the AP sequence (first row) or the PA sequence (second row). All
subjects had a washout period between the two treatment periods
Subject 1 (R) Washout Subject 2 (G)
Period 1 2 —– 1 2
Sequence 1 RA RP —– GA GP
Sequence 2 RP RA —– GP GA
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for each missing data pattern. The distribution pi[yi|Xi,mi] models the within-
subject regressions for each missing data pattern, and pi[mi|Xi] models the marginal
proportions of each missing data pattern as functions of between-subject covariates.
It should be noted that there does exist a more general random-coefficient
pattern-mixture model, e.g., see Little [7]. We do not pursue the more general
model here, however, because our crossover model for the BARGE Study assumes
that only one measurement is made in each period.
The type of “missingness” that exists really should dictate our final analysis.
Rubin [8] and Little and Rubin [9] describe three types of missingness for which
we need not apply a pattern-mixture model: i) if the data are missing completely
at random (the probability of response is independent of both the observed and
unobserved data); ii) if covariate-dependent dropout exists (the missingness depends
on fixed covariates in the model); and iii) if the data are missing at random (the
probability of response depends on the observed data but not the missing data). In
any of these three cases, we simply can apply a general linear model with correlated
errors to the data arising from a paired crossover design, as was performed by
Simon and Chinchilli [10]. The resulting likelihood-based estimation and inference
procedures are asymptotically unbiased.
If the missing values satisfy none of the three types mentioned above, then Lit-
tle and Rubin [9] label the situation “non-ignorable” (the probability of response
depends on the unobserved data), and the analysis of the available data require
special methods. In this situation, when analyzing the data arising from a paired
crossover design, we propose applying the pattern-mixture model methods that we
now describe.
2. Methods
In defining a pattern-mixture model for a paired 2 × 2 crossover experiment, we
assume that each subject is scheduled to contribute one response per period. The
response may truly be a single post-treatment, outcome measure, such as forced
expiratory volume in one second (“FEV1”) in an asthma trial. Alternatively, and
perhaps more commonly, the response could be a summary of multiple, repeated
outcome measures, such as the change in response from pre- to post-treatment or the
area under a dose-response curve (“AUC”) in a bioequivalence trial. We also assume
that the subjects do not contribute any additional covariates. Thus, in general, if
we refer to the two types of subjects who are matched as 1 and 2 and we label the
treatments as A and B, then we expect each pair of subjects j of sequence s to
yield only the quadrivariate response Ysj = (Ysj1A, Ysj1B , Ysj2A, Ysj2B). To define
a pattern-mixture model for a paired 2×2 crossover design that accommodates non-
ignorable missing data, we must first consider the possible patterns of missingness.
2.1. Patterns of missingness
When modeling missing data in a clinical trial, it is common to assume that the
missingness happens monotonically, i.e., after the first missing data point for a
subject, all of the subsequent anticipated data points for that subject are also
missing. For example, the data vector for a subject i might look something like
yi = (yi1, yi2, yi3, ·, ·, ·)′ assuming the subject misses all measurement occasions
after the third occasion. The monotonic missingness assumption greatly simplifies
the model development and subsequent analysis.
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Unfortunately, for a paired crossover design, the monotonicity assumption is not
realistic. The data vector ysj for the paired 2 × 2 crossover design contains data
on the two subjects within a pair. Therefore, data vectors with non-monotonic
missingness that look like ysj = (ysj1A, ·, ysj2A, ·)′ are quite possible in a paired
crossover design. One could still hope to simplify the problem by assuming that
at least the missingness with respect to each subject is monotonic. However, the
BARGE Study data set, to which we later apply the methods described herein,
contains non-monotonic missingness within subjects. Therefore, we do not make
any simplifying assumptions, but instead address the problem in its full generality.
Another complication of handling missing data in a crossover design (paired
or otherwise) is that, even when the same pattern of missingness occurs, different
information is gleaned about the treatments from the subjects in different sequences.
For example, for our paired 2×2 crossover design, data vectors for the first sequence,
y1j , which are missing the last data point:
y1j = (y1j1A, y1j1B , y1j2A, ·)′
provide no information about the type 2-treatment B combination, while data vec-
tors for the second sequence, y2j , which are missing the last data point:
y2j = (y2j1B , y2j1A, y2j2B, ·)′
provide no information about the type 2-treatment A combination. Therefore,
pattern-mixture models for any crossover design must accommodate patterns of
missingness for each of the sequences.
Let Pps denote the pattern of missingness for pattern p = 0, 1, . . . , 14 for sequence
s = 1, 2. Table 2 summarizes, for the paired 2 × 2 crossover design, the eight
potential patterns of missingness that are monotonic within subject, while Table 3
summarizes the remaining seven patterns of missingness that are not monotonic
within subject.
Table 2
Eight patterns of missingness in paired 2-by-2 crossover design that are monotonic
within subject. X denotes observed and ? denotes missing
Subject 1 (R) Subject 2 (G)
Pattern Sequence Per 1 Per 2 Per 1 Per 2
P01 1 (AB) X X X X
P02 2 (BA) X X X X
P11 1 (AB) X X X ?
P12 2 (BA) X X X ?
P21 1 (AB) X ? X X
P22 2 (BA) X ? X X
P31 1 (AB) X ? X ?
P32 2 (BA) X ? X ?
P41 1 (AB) X X ? ?
P42 2 (BA) X X ? ?
P51 1 (AB) ? ? X X
P52 2 (BA) ? ? X X
P61 1 (AB) X ? ? ?
P62 2 (BA) X ? ? ?
P71 1 (AB) ? ? X ?
P72 2 (BA) ? ? X ?
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Table 3
Seven patterns of missingness in paired 2-by-2 crossover design that are non-monotonic
within subject. X denotes observed and ? denotes missing
Subject 1 (R) Subject 2 (G)
Pattern Sequence Per 1 Per 2 Per 1 Per 2
P81 1 (AB) ? ? ? X
P82 2 (BA) ? ? ? X
P91 1 (AB) ? X ? ?
P92 2 (BA) ? X ? ?
P10,1 1 (AB) ? X X X
P10,2 2 (BA) ? X X X
P11,1 1 (AB) X X ? X
P11,2 2 (BA) X X ? X
P12,1 1 (AB) ? X ? X
P12,2 2 (BA) ? X ? X
P13,1 1 (AB) ? X X ?
P13,2 2 (BA) ? X X ?
P14,1 1 (AB) X ? ? X
P14,2 2 (BA) X ? ? X
Complicating issues arise when modeling the data from a 2× 2 crossover experi-
ment even when the data are complete. Therefore, before defining a pattern-mixture
model that accommodates non-ignorable missing data, we first define a statistical
model assuming the data are complete.
2.2. A paired 2× 2 crossover model for complete data
In defining a statistical model for the paired 2 × 2 crossover design, one of the
complicating issues is the handling of “treatment carryover.” In an AB sequence,
a subject receives treatment A in the first period and treatment B in the second
period. In this case, the “A carryover” (λA) is the component of the response in the
second period due to the lasting effect of treatment A from the first period (Jones
and Kenward [2], Ratkowsky et al. [3] and Senn [4]). Likewise, in a BA sequence,
the “B carryover” (λB) is the component of the response in the second period due
to the lasting effect of treatment B from the first period. In a 2 × 2 crossover, if
the magnitude of the A carryover differs from that of the B carryover (λA 6= λB),
it is not possible to estimate the primary quantity of interest – the true treatment
effect µA − µB.
There are two situations in which it is possible to estimate the true treatment
effect: 1) if the carryover effects are the same for each treatment (λA = λB); or
2) if the time periods between the treatment periods, i.e., the washout periods,
are designed to be lengthy enough to render both carryover effects negligible (λA =
λB = 0). Most 2×2 crossover experiments – the BARGE Study included – institute
a substantial washout period between the treatment periods with the intent of
eliminating any carryover effects. We therefore proceed in formulating a model
assuming the second situation holds. In general, if unequal carryover effects are
suspected to exist, then a design more complex than the 2× 2 crossover is needed.
A general linear model with correlated errors – which is a special case of the
general linear mixed-effects model described by Laird and Ware [11] – for the paired
2× 2 crossover design with null carryover effects can be applied and is stated as:
Ysj = Xsjβ + εsj ,
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where:
• Ysj = (Ysj1A, Ysj1B , Ysj2A, Ysj2B)′ is the quadrivariate response for pair j
(1, 2, . . . , ns) of sequence s (1 = AB, 2 = BA).
• Xsj is a 4×8 fixed-effects design matrix (in a complete data situation,X1j and
X2j do not depend on j, i.e., Xsj = Xs for all s = 1, 2 and j = 1, 2, . . . , ns).
• β = (µ1A, µ1B, µ2A, µ2B, ρ1, ρ2, ν1, ν2)′ is an 8× 1 fixed-effects parameter vec-
tor containing four type-by-treatment means, two type-by-period effects, and
two type-by-sequence effects.
• εsj = (εsj1A, εsj1B , εsj2A, εsj2B)′ is a random error term.
The mean of the responses derives directly from the Xsjβ portion of the model,
while the variance of the responses derives directly from the εsj portion of the
model.
2.2.1. Mean of the responses
Our proposed model for the mean of the responses arising from a paired 2 × 2
crossover design is a straightforward extension of the model commonly assumed for
the mean of the responses arising from a basic 2 × 2 crossover design. That is, we
assume that the mean of the response in any cell of the paired 2×2 crossover design
is a function of the subject type and treatment (µkl), as well as the period (ρk)
and sequence (νl) in which the treatments are taken. More specifically, we propose
parameterizing the mean of the responses as:
Type Sequence Period 1 Period 2
1 AB µ1A + ρ1 + ν1 µ1B − ρ1 + ν1
1 BA µ1B + ρ1 − ν1 µ1A − ρ1 − ν1
2 AB µ2A + ρ2 + ν2 µ2B − ρ2 + ν2
2 BA µ2B + ρ2 − ν2 µ2A − ρ2 − ν2
2.2.2. Variance of the responses
Traditionally, the variance matrix for a crossover design is assumed to be compound
symmetric. That is, the variance of the responses arising from one treatment is
assumed to equal the variances of the responses arising from other treatments. And,
the covariances between the responses of the subjects when on different treatments
are also assumed to be equal. Like the approach of others (Ekbohm and Melander
[12], Sheiner [13], Chinchilli and Esinhart [14] and Putt and Chinchilli [15]), we
instead model the maximum number of variance components permitted for the
paired 2×2 crossover design. That is, the variance, Σ, of the response Ysj , s = 1, 2:
σ1A,1A σ1A,1B σ1A,2A σ1A,2B
σ1A,1B σ1B,1B σ1B,2A σ1B,2B
σ1A,2A σ1B,2A σ2A,2A σ2A,2B
σ1A,2B σ1B,2B σ2A,2B σ2B,2B

is much more flexible than the compound symmetric structure traditionally as-
sumed.
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2.2.3. The data
As the paired 2 × 2 crossover model for the complete data situation suggests, we
assume that the data are balanced (the occasions of measurement are the same for
all subjects) and complete (measurements are available at each planned occasion
for each subject). However, the model is appropriate even when the data are not
complete but the missingness occurs at random (the probability of response depends
on the observed data but not the missing data). We now define a pattern-mixture
model for when the missingness is non-ignorable.
2.3. A pattern-mixture model
Attempting to define a model for each of the fifteen missing data patterns yields
identifiability problems. Some of the patterns will naturally be more populated,
while others will be sparsely populated at best. For the sake of illustration, Table
4 summarizes the number of subject pairs in the BARGE Study falling into each
of the fifteen missing data patterns. Table 4 indicates that there were no non-
monotonic patterns observed in the BARGE Study, which is not suprising because
of the longitudinal nature of the trial design.
In general, because of the inherent identifiability problems, it is necessary to
collapse the fifteen patterns into coarser groupings, so that information about the
effects parameters can be “borrowed” across the patterns. When considering po-
tential groupings, one should take into account the area of scientific research, as
well as the various characteristics of the subjects and/or pairs that might yield
group differences. In creating groupings for the BARGE Study data, we propose
the formation of the following three groups:
1. A group containing the completers who have a pair match – patterns 0, 10,
11, and 12. This group is denoted group “C” for “completers.”
2. A group in which all patterns involve missing a second period, regardless of
whether a pair match exists – patterns 1, 2, 3, 6, 7, 13 and 14. This group is
denoted group “D” for missingness due to “dropout.”
3. A group of the patterns in which a subject is a completer but does not have
a pair match – patterns 4, 5, 8 and 9. This group is denoted group “P” for
missingness due to a missing “pair.”
Collapsing the counts in Table 4 for the BARGE Study according to these criteria
yields that nC = 29, nD = 6, and nP = 5.
It should be emphasized that other groupings are possible besides the one that
we propose. Some of the other groupings, however, require one to assume that no
period and no sequence effects exist. That is an assumption that we were unwilling
to make for the BARGE Study. It should be noted, though, that if there were no
Table 4
Frequencies of patterns observed in the BARGE Study
Pattern Count Pattern Count Pattern Count
0 29 5 2 10 0
1 1 6 1 11 0
2 1 7 3 12 0
3 0 8 0 13 0
4 3 9 0 14 0
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period nor sequence effects to worry about, the methods described by Little (1995)
could be applied instead.
Now that our groupings are defined, let:
• Ysj denote the 4× 1 complete data vector for pair j in sequence s.
• Ypsj denote the r × 1 observed (reduced) data vector for pair j in pattern p
and sequence s.
• β(g) = (µ(g)1A , µ(g)1B, µ(g)2A , µ(g)2B, ρ(g)1 , ρ(g)2 , ν(g)1 , ν(g)2 )′ denote the 8× 1 fixed effects
location parameter vector for group g = C,D, and P.
• Xsj denote the 4 × 8 design matrix for pair j in sequence s = 1, 2 that links
the complete data vector Ysj to β
(C).
• Σ denote the 4×4 complete variance-covariance matrix (as defined previously)
for the complete data vector Ysj (notice that we do not assume that the
variance-covariance parameters differ across the patterns).
• Eps be an r × 4 submatrix of the 4 × 4 identity matrix for pattern p and
sequence s, in which rows of the identity matrix are removed according to the
missing values in Ysj . The rows of the identity matrix are always considered
in 1A, 1B, 2A, 2B order, and r equals the number of non-missing observations.
Then, we define our pattern-mixture model as:
Ypsj = EpsYsj ∼ Nr
(
EpsXsjβ
(g),EpsΣE
′
ps
)
,
where g = C for patterns p = 0, 10, 11, and 12; g = D for patterns p = 1, 2, 3, 6, 7, 13
and 14; and g = P for patterns p = 4, 5, 8 and 9.
For example, pattern p = 2 and sequence s = 1 is missing the 1B measurement.
Therefore, r = 3 and:
E21 =
 1 0 0 00 0 1 0
0 0 0 1
 .
The mean of the response Y21j = (Y21j1A, Y21j2A, Y21j2B)
′ is:
E21X1jβ
(D) =
 µ
(D)
1A + ρ
(D)
1 + ν
(D)
1
µ
(D)
2A + ρ
(D)
2 + ν
(D)
2
µ
(D)
2B − ρ(D)2 + ν(D)2

and the 3× 3 variance-covariance matrix is:
E21ΣE
′
21 =
 σ1A,1A σ1A,2A σ1A,2Bσ1A,2A σ2A,2A σ2A,2B
σ1A,2B σ2A,2B σ2B,2B
 .
The proposed means and variances of the remaining patterns p and sequences s
can be obtained similarly.
2.4. Maximum likelihood estimation
We can readily obtain maximum likelihood (ML) estimates of the parameters of our
pattern-mixture model using available software such as PROC MIXED in SAS 9.1.
The following is sample code from SAS PROC MIXED that can be used to find
the ML estimates of the covariance parameters and the pattern-specific location
parameters:
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PROC MIXED DATA = barge METHOD = ML;
CLASS pairid position grp;
MODEL response = mu1A(grp) mu1B(grp) mu2A(grp) mu2B(grp)
rho1(grp) rho2(grp) nu1(grp) nu2(grp)/NOINT S;
REPEATED position / SUBJECT = pairid TYPE = UN;
RUN;
The variable pairid represents the identification number of the pairs. The variable
position represents the order of the data in the pair’s quadrivariate response vector:
1A is position 1, 1B is position 2, 2A is position 3 and 2B is position 4. The variable
grp represents the three groups of patterns: for our example, groups C, D, and P.
As an alternative to using SAS PROC MIXED, we can use the log-likelihood
function and a matrix programming language, such as S-Plus or SAS/IML, to write
our own Fisher scoring or Newton-Raphson algorithm to find the ML estimates.
Let:
• nps denote the number of pairs falling in pattern p of sequence s, and ns
denote the number of pairs falling in sequence s.
• pips denote the true proportion of pairs falling in pattern p of sequence s.
• φid denote the set of 62 identifiable parameters – 24 effects (µ(C)1A , . . . , ν(P )2 ), 28
proportions (pi01, pi02, . . . , pi13,1, pi13,2), and 10 covariance parameters (σ1A,1A,
. . . , σ2B,2B).
Then, letting Σ∗ps = EpsΣE
′
ps and using Lagrange multipliers λ1 and λ2 with
constraints pi01 + · · · + pi14,1 = 1 and pi02 + · · · + pi14,2 = 1, respectively, the log
likelihood function is:
logLY,n (φid) ≈[
14∑
p=0
2∑
s=1
nps log pips
]
− λ1 (1− pi01 − · · · − pi14,1)
−λ2 (1− pi02 − · · · − pi14,2) 1
2
14∑
p=0
2∑
s=1
nps∑
j=1
log
∣∣Σ∗ps∣∣
−1
2
14∑
p=0
2∑
s=1
nps∑
j=1
(
Epsysj −EpsXsjβ(g)
)′
Σ∗−1ps
(
Epsysj −EpsXsjβ(g)
)
where the value of g depends on pattern p (g = C for p = 0, 10, 11, 12; g = D for
p = 1, 2, 3, 6, 7, 13, 14; and g = P for p = 4, 5, 8, 9).
2.5. Restricted maximum likelihood estimation
Just as is the case for ML estimation, it is possible to use SAS PROCMIXED to find
restricted maximum likelihood (REML) estimates of the parameters of the pattern
mixture model. We only need to make one minor modification to the SAS PROC
MIXED code previously used to find the ML estimates (change the “METHOD =
ML” option to “METHOD = REML” option).
Again, alternatively we can use the restricted likelihood function and a matrix
programming language, such as S-Plus or SAS/IML, to write one’s own Fisher
scoring or Newton-Raphson algorithm to find the REML estimates.
Let:
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• n = (n01, . . . , n14,2)′ be the vector of sample sizes nps for pattern p and
sequence s (with N =
∑14
p=0
∑2
s=1 nps).
• pi = (pi01, . . . , pi14,2)′ be the vector of true population proportions for pattern
p and sequence s.
• Y = (y011, . . . ,y01n01 , . . . ,y14,21, . . . ,y14,2n14,2)′ be the N × 1 vector of the
entire set of observed responses.
• β = (β(C)′, β(D)′, β(P )′)′ be the 24× 1 vector of fixed effect location parame-
ters.
• X be the N × 24 full design matrix linking Y to β.
• Ω be the N ×N block-diagonal variance-covariance matrix of Y.
• θ be a vector containing the 10 identifiable variance components (σ1A,1A, . . . ,
σ2B,2B).
Then the joint likelihood of Y and n can be written as the factorization:
LY,n (φid) = LY|n (β, θ)× Ln (pi) ,
where Y|n is a multivariate N -normal with mean Xβ and variance Ω, and n is
multinomial with parameters N and pi. Then, the general procedure behind REML
estimation of transforming the data vector Y|n such that the likelihood LY|n(β, θ)
factors into two components can be applied, yielding:
logLY,n (φid) = logL
′ (θ) + logL′′ (β, θ) + logLn (pi) .
Letting P = Ω−1−Ω−1X(X′Ω−1X)−1X′Ω−1, the log REML likelihood function
is:
logL′ (θ) ≈ −1
2
log |Ω| − 1
2
log
∣∣X′Ω−1X∣∣− 1
2
Y′PY
and:
logL′′ (β, θ) = −1
2
log
∣∣∣(X′Ω−1X)−1∣∣∣− 1
2
(
β̂−β
)′ (
X′Ω−1X
) (
β̂−β
)
,
where β̂ has the form of the generalized least squares (GLS) estimator β̂ =
(X′Ω−1X)−1X′Ω−1Y. Using Lagrange multipliers, logLn(pi) is the log-likelihood
of the two independent multinomial samples:
logLn (pi) =
[
14∑
p=0
2∑
s=1
nps log pips
]
− λ1 (1− pi01 − · · · − pi14,1)
−λ2 (1− pi02 − · · · − pi14,2)
2.6. Inference about γ
Thus far, we only have addressed estimation of the pattern-specific parameters,
such as µ
(C)
1A , ρ
(D)
1 , and ν
(P )
1 . Interest, however, typically lies in inference about the
overall population parameters, such as µ1A, ρ1, and ν1, not the pattern-specific
ones. Therefore, here we extend our work of the previous sections by addressing es-
timation of the overall population parameters. Furthermore, since use of the paired
2 × 2 crossover design will often be motivated by interest in inference about the
interaction parameter:
γ = (µ1A − µ1B)− (µ2A − µ2B) ,
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we also derive the asymptotic distribution of γ̂ here. Since the expression for the
point estimator γ̂ and the form of the asymptotic distribution of γ̂ are the same
regardless of whether REML or ML estimation is used in obtaining γ̂, for the sake
of simplicity, we proceed assuming that ML estimation is used.
In order to define point estimators of the overall population parameters, let pig
denote the proportion of pairs in group g for g = C,D, and P. Then, for k = 1, 2
and l = A,B, the weighted average:
µ̂kl = piC µ̂
(C)
kl + piDµ̂
(D)
kl + piP µ̂
(P )
kl(2.1)
= piC µ̂
(C)
kl + piDµ̂
(D)
kl + (1− piC − piD) µ̂(P )kl
is the ML estimator of the overall population treatment-by-genotype mean. And,
therefore γ̂ = (µ̂1A − µ̂1B)− (µ̂2A − µ̂2B) is the ML estimator of γ.
The estimator γ̂ is a function of pig and µ̂
(g)
kl , the estimated proportions and
pattern-specific means. Therefore, we derive the asymptotic distribution of γ̂ by
first using the asymptotic normality of ML estimators and then by an application
of the delta method.
Let:
• pi = (piC , piD)′ be the 2×1 vector containing the estimated proportion of pairs
falling into each of the first two groups.
• pi = (piC , piD)′ be the 2 × 1 vector containing the corresponding two true
proportions.
• V(pi) = Diag(pi)− pipi′ denote the 2× 2 variance matrix of pi.
• µ̂ = (µ̂(C)1A , µ̂(D)1A , µ̂(P )1A , . . . , µ̂(C)2B , µ̂(D)2B , µ̂(P )2B ) be the 12×1 vector containing the
estimated pattern-specific mean parameters.
• µ = (µ(C)1A , µ(D)1A , µ(P )1A , . . . , µ(C)2B , µ(D)2B , µ(P )2B ) be the 12×1 vector containing the
corresponding true pattern-specific mean parameters.
• V(µ̂) denote the 12× 12 variance matrix of µ̂.
Then, by the asymptotic normality of maximum likelihood estimators and by
the independence of pi and µ̂ :
√
N
((
piN
µ̂N
)
−
(
pi
µ
))
is asymptotically multivariate normal with mean 014×1 and 14 × 14 variance-
covariance matrix:
V =
(
V (pi)2×2 02×12
012×2 V (µ̂)12×12
)
.
Now, defining the 4×1 vector of functions g((pi′, µ̂′)′) = (µ̂1A, µ̂1B , µ̂2A, µ̂2B)′ where
the functions µ̂1A, µ̂1B, µ̂2A and µ̂2B are as defined by (2.1), the 4 × 14 Jacobian
matrix equals J =[J1|J2] where J1 is the 4× 2 matrix:
J1 =

µ̂
(C)
1A − µ̂(P )1A µ̂(D)1A − µ̂(P )1A
µ̂
(C)
1B − µ̂(P )1B µ̂(D)1B − µ̂(P )1B
µ̂
(C)
2A − µ̂(P )2A µ̂(D)2A − µ̂(P )2A
µ̂
(C)
2B − µ̂(P )2B µ̂(D)2B − µ̂(P )2B

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and J2 is the 4× 12 matrix:
J2=

piC piD piP 0 0 0 0 0 0 0 0 0
0 0 0 piC piD piP 0 0 0 0 0 0
0 0 0 0 0 0 piC piD piP 0 0 0
0 0 0 0 0 0 0 0 0 piC piD piP
 .
Then, an application of the delta method yields that:
√
N


µ̂1A
µ̂1B
µ̂2A
µ̂2B
−

µ1A
µ1B
µ2A
µ2B


is asymptotically multivariate normal with mean 04×1 and 4 × 4 variance matrix
JVJ′.
Now, we can construct any linear combination of the population mean parame-
ters as γ = c′(µ1A, µ1B, µ2A, µ2B)
′, but the contrast vector of particular interest in
our application is:
c =
(
1 −1 −1 1 )′ .
Then
γ̂ = g
((
µ̂1A µ̂1B µ̂2A µ̂2B
)′)
= c′ (µ̂1A, µ̂1B, µ̂2A, µ̂2B)
′
and
∂γ̂
∂
(
µ̂1A µ̂1B µ̂2A µ̂2B
) = c′.
Therefore, one final application of the delta method yields that
√
N(γ̂−γ) is asymp-
totically normal with mean 0 and variance V (γ̂) = c′JVJ′c. The resulting asymp-
totic variance V (γ̂) depends on pig, µ̂
(g)
kl , V(pi) and V(µ̂), and therefore must be
estimated.
3. Results
As described in the Introduction, the BARGE Study was a randomized paired
2×2 crossover trial in asthma patients comparing the effects of regularly-scheduled
inhaled albuterol to placebo (Israel et al. [6]). Patients who met the asthma eligi-
bility criteria were genotyped at the 16th position of the beta-agonist receptor gene
(Arg/Arg, Gly/Gly, Arg/Gly). The heterozygotes (Arg/Gly) were excluded from
the study. The Arg/Arg and Gly/Gly patients, on the other hand, were matched
according to their pulmonary function (as determined by their forced expiratory
volume in one second) and randomized together to the same treatment sequence.
The primary outcome variable was the difference in the patients’ morning peak ex-
piratory flow rates (AM PEFR, measured in liters per minute) at the start and end
of the 16-week treatment periods. A change of 25 liters per minute was the effect
size considered to be clinically meaningful for the sample size calculation made for
the BARGE study protocol.
The BARGE Study consisted of 78 randomized patients, of whom 71 yielded data
for analysis – 35 with the Arg/Arg genotype and 36 with the Gly/Gly genotype at
the 16th position of the beta-agonist receptor gene. There were 40 sets of subjects,
and as mentioned in Section 2.3, nC = 29, nD = 6, and nP = 5. Because of the small
samples sizes for groups D and P, which yielded non-estimable standard errors for
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some of their estimated parameters, these two groups were pooled. Thus, the final
pattern-mixture model for the analysis of the BARGE Study data consisted of only
two groups (C and D+P).
A general linear model with correlated errors, as described in Sections 2.4 and
2.5, was applied to group C and group D+P separately that included effects for
period, sequence, and treatment. Because group D+P had a small sample size, a
common 4×4 variance-covariance matrix was assumed for group C and group D+P.
The REML estimates for the treatment effects, along with their standard errors,
appear in Table 5. It is not surprising that the standard errors for the treatment
effect estimates in group D+P are much larger than those of group C because (1)
group C consisted of 29 sets of patients with 116 observations, and (2) group D+P
consisted of 11 sets of patients with 20 observations. The REML estimates for
the weighted averages of the treatment effects, along with standard errors, appear
in Table 6, based on the pattern-mixture methodology described in the previous
section.
The estimate of γ = (µRA − µRP ) − (µGA − µGP ), the genotype × treatment
interaction term, is –11.7 liters per minute with standard error 22.3 (p = 0.60).
Thus, the analysis based on the proposed pattern-mixture model does not yield
a statistically significant result. If the patterns (groups C and D+P) are ignored
in the analysis, then the estimate of γ is −15.8 liters per minute with standard
error 19.4 (p = 0.42). Although the results of the two analyses (with and without
pattern-mixture modeling) yield similar scientific conclusions, the analysis based
on the proposed pattern-mixture model is slightly more conservative.
In the BARGE scientific manuscript, Israel et al. [6] applied a mixed-effects linear
model to the repeated measurements data within each of the 16-week treatment
periods. In other words, they used all of the available data, not just the patients’
final 16-week measurement minus their baseline measurement. Such an approach
Table 5
The REML estimates of the treatment effects from the mixed-effects model analysis of groups C
and D+P separately. Arg/Arg = R, Gly/Gly = G, Albuterol = A, Placebo = P
Change in AM PEFR
Group Genotype Treatment µ̂
(g)
kl
= Mean (Std Error)
C Arg/Arg Placebo µ̂
(C)
RP
= 20.4 (11.7)
C Arg/Arg Albuterol µ̂
(C)
RA
= 8.1 (10.3)
C Gly/Gly Placebo µ̂
(C)
GP
= 12.6 (17.7)
C Gly/Gly Albuterol µ̂
(C)
GA
= 22.3 (20.3)
D+P Arg/Arg Placebo µ̂
(D+P )
RP
= −23.7 (35.7)
D+P Arg/Arg Albuterol µ̂
(D+P )
RA
= 12.0 (40.1)
D+P Gly/Gly Placebo µ̂
(D+P )
GP
= −66.8 (45.5)
D+P Gly/Gly Albuterol µ̂
(D+P )
GP
= −46.4 (45.4)
Table 6
The REML estimates of the weighted averages of the treatment effects from the mixed-effects
model analysis. Arg/Arg = R, Gly/Gly = G, Albuterol = A, Placebo = P
Change in AM PEFR
Genotype Treatment Mean (Std Error)
Arg/Arg Placebo µ̂RP = 8.3 (13.0)
Arg/Arg Albuterol µ̂RA = 9.2 (13.3)
Gly/Gly Placebo µ̂GP = −9.2 (17.9)
Gly/Gly Albuterol µ̂GA = 3.4 (19.3)
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yielded a more powerful and sensitive analysis than the analysis described here
because many of the patients in pattern-mixture group D had partial data during
the 16-week treatment periods which contributed to the overall analysis. Indeed, the
authors of the BARGE manuscript estimated the genotype × treatment interaction
term as 24.0 liters per minute with standard error 6.3 (p < 0.01). In a future
communication, we plan to develop the pattern-mixture version of the mixed-effects
linear model for the paired 2× 2 crossover design that will accommodate repeated
measurements within the randomized treatment periods.
4. Discussion
We have demonstrated the development of a pattern-mixture version of a general
linear model with correlated errors for the paired 2 × 2 crossover design. As just
mentioned, in a future communication we will extend our work described herein to
account for repeated measurements within the randomized treatment periods. Such
an approach will optimize the pattern mixture approach because dropouts could
be redefined as early dropouts or late dropouts.
A weakness of the pattern mixture approach to the analysis of data from a paired
2 × 2 crossover design is that one or more of the pattern groups could represent
a reasonable proportion of the sample, yet provide little data for analysis. Case in
point, this occurred with the BARGE Study data presented here. Eleven of the 40
sets (27.5%) were categorized into group D+P, yet group D+P provided only 20 of
the 136 observations (14.7%) in the data set. Thus, the influence of group D+P on
the results of the analysis is disproportionate to the actual number of observations
that it contributes to the analysis. This weakness could be minimized by using
available repeated measurements within the randomized treatment periods.
One popular alternative to the pattern-mixture model approach is multiple data
imputation (e.g., see Schafer [16]). Multiple data imputation involves the construc-
tion of a complete data set via estimation of the missing values according to an
appropriate probability model, repeating this m times, estimating the treatment
effects within each data set, and averaging the effects across the m data sets. Mul-
tiple data imputation affords two advantages: (1) it provides complete data sets
that are more easily analyzed via standard statistical methods, and (2) it appropri-
ately accounts for the variability in estimating the missing values. The disadvantage
of multiple data imputation is that the probability model for generating imputed
values could be misspecified. If so, then the combined results could be biased. For
example, the probability model may be based on the estimated mean and vari-
ance structure of those experimental units with complete observations. If the data
from dropouts have an inherently different mean and variance structure, then the
imputed values could be misrepresentative.
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